Related references
Note: Only part of the references are listed.Oxidative stress in drug-na⟨ve first episode patients with schizophrenia and major depression: effects of disease acuity and potential confounders
Wolfgang Jordan et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2018)
Investigating Shared Aetiology Between Type 2 Diabetes and Major Depressive Disorder in a Population Based Cohort
Toni-Kim Clarke et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2017)
Assessment of Insulin Resistance Among Drug-Naive Patients With First-Episode Schizophrenia in the Context of Hormonal Stress Axis Activation
Johann Steiner et al.
JAMA PSYCHIATRY (2017)
Impaired Glucose Homeostasis in First-Episode Schizophrenia A Systematic Review and Meta-analysis
Toby Pillinger et al.
JAMA PSYCHIATRY (2017)
Immune system and glucose metabolism interaction in schizophrenia: A chicken-egg dilemma
Johann Steiner et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2014)
Is Ignorance Bliss? Depression, Antidepressants, and the Diagnosis of Prediabetes and Type 2 Diabetes
Briana Mezuk et al.
HEALTH PSYCHOLOGY (2013)
The change of insulin levels after six weeks antidepressant use in drug-naive major depressive patients
Hui Hua Chang et al.
JOURNAL OF AFFECTIVE DISORDERS (2013)
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
Stefan Leucht et al.
LANCET (2013)
Depression and Type 2 Diabetes Over the Lifespan A meta-analysis
Briana Mezuk et al.
DIABETES CARE (2008)
Insulin sensitivity, proinflammatory markers and adiponectin in young males with different subtypes of depressive disorder
Yi-Jen Hung et al.
CLINICAL ENDOCRINOLOGY (2007)
Metabolic profiling of CSF: Evidence that early intervention may impact on disease progression and outcome in schizophrenia
Elaine Holmes et al.
PLOS MEDICINE (2006)
The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms
RS McIntyre et al.
EXPERT OPINION ON DRUG SAFETY (2006)
Lipid metabolism and insulin resistance in depressed patients - Significance of weight, hypercortisolism, and antidepressant treatment
D Kopf et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2004)
Major depression and impaired glucose tolerance
B Weber et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2000)